Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One For every family touched by Parkinson's disease, this is research you deserve to know about. Glutathione levels in the substantia nigra, the brain region most devastated by Parkinson's ,are depleted by up Glutathione IV Therapy The Parkinson's Plan Randomized, double'blind, pilot evaluation of intravenous glutathione in Parkinson's disease